子宮內膜消融市場規模、佔有率和成長分析（按產品、最終用途和地區）- 行業預測 2025-2032

Endometrial Ablation Market Size, Share, and Growth Analysis, By Product (Cryoablation, Radiofrequency Ablation), By End-use (Hospitals, Clinics), By Region - Industry Forecast 2025-2032

出版日期: 2025年02月22日 | 出版商:

SkyQuest | 英文 219 Pages | 商品交期: 3-5個工作天內

價格

簡介目錄

2023 年子宮內膜消融市場規模價值 20.7 億美元，預計將從 2024 年的 22 億美元成長到 2032 年的 35.3 億美元，預測期內（2025-2032 年）的複合年成長率為 6.1%。

由於婦科疾病（例如月經、多囊性卵巢症候群、異常陰道出血等）的盛行率不斷上升，以及人們對這些手術的益處的認知不斷提高，子宮內膜消融手術和設備市場正在經歷顯著成長。每年約有 1000 萬美國女性受到經痛的影響，全球 3%-30% 的育齡婦女患有異常子宮出血 (AUB)，因此對可月經降低風險和併發症的微創手術的需求日益成長。政府和私人醫療機構都將女性健康放在首位，印度等國家正在實施醫療保險免稅等舉措，以鼓勵女性接受治療。儘管該手術存在潛在風險，但 AUB 的持續流行表明市場對有效解決方案的需求永續。

北美洲
- 美國
- 加拿大
歐洲
- 德國
- 西班牙
- 法國
- 英國
- 義大利
- 其他歐洲國家地區
亞太地區
- 中國
- 印度
- 日本
- 韓國
- 其他亞太地區
拉丁美洲
- 巴西
- 其他拉丁美洲國家
中東和非洲
- 海灣合作理事會國家
- 南非
- 其他中東和非洲地區

競爭資訊

前 5 家公司對比
主要企業市場定位（2024年）
主要市場參與者所採用的策略
近期市場趨勢
公司市場佔有率分析（2024 年）
主要企業簡介
- 公司詳細資訊
- 產品系列分析
- 公司分部佔有率分析
- 收益與前一年同期比較對比（2022-2024 年）

主要企業簡介

Hologic, Inc.（United States）
Boston Scientific Corporation（United States）
Medtronic plc（Ireland）
CooperSurgical Inc.（United States）
Olympus Corporation（Japan）
Smith & Nephew plc（United Kingdom）
Minerva Surgical, Inc.（United States）
Ethicon, Inc.（Johnson & Johnson）（United States）
AngioDynamics, Inc.（United States）
Myosure（Hologic, Inc.）（United States）

結論和建議

簡介目錄

Product Code: SQMIG35A2573

Endometrial Ablation Market size was valued at USD 2.07 billion in 2023 and is poised to grow from USD 2.20 billion in 2024 to USD 3.53 billion by 2032, growing at a CAGR of 6.1% during the forecast period (2025-2032).

The market for endometrial ablation procedures and devices is witnessing significant growth due to the rising incidence of gynecological disorders such as menorrhagia, PCOD, and abnormal vaginal bleeding, coupled with increased awareness of the benefits these procedures offer. With approximately 10 million American women affected by menorrhagia each year, along with 3 to 30% of reproductive-aged women globally experiencing Abnormal Uterine Bleeding (AUB), the demand for minimally invasive techniques that minimize risk and complexity is on the rise. Governments and private health organizations are prioritizing women's health, implementing initiatives like tax exemptions for health insurance in countries like India to encourage treatment adoption. Despite potential risks associated with the procedures, the consistent prevalence of AUB underscores a sustainable demand for effective solutions in the market.

Top-down and bottom-up approaches were used to estimate and validate the size of the Endometrial Ablation market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Endometrial Ablation Market Segments Analysis

Global Endometrial Ablation Market is segmented by Product, End-use and region. Based on Product, the market is segmented into Cryoablation, Radiofrequency Ablation, Hydrothermal Ablation, Thermal Balloon, Microwave Energy and Others. Based on End-use, the market is segmented into Hospitals, Clinics and Ambulatory Surgical Centers. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Endometrial Ablation Market

The rise in the prevalence of gynecological conditions, including menorrhagia, abnormal vaginal bleeding, and polycystic ovary syndrome (PCOS), significantly propels the growth of the endometrial ablation market. As these disorders become more common, there is an escalating need for effective and minimally invasive treatment alternatives, prompting patients and healthcare providers to seek solutions such as endometrial ablation. This growing awareness and demand for less invasive procedures not only highlight the urgency of addressing these health issues but also contribute to the overall expansion of the endometrial ablation market, making it a key area of focus for medical professionals and manufacturers alike.

Restraints in the Endometrial Ablation Market

The endometrial ablation market faces several restraints due to the procedure's limitations and associated risks. Not every patient is a suitable candidate for endometrial ablation, and the potential for complications can deter both patients and practitioners from pursuing this treatment option. Adverse effects such as infections, accidental tearing of the uterine wall or bowel, and other unintended outcomes may further restrict market expansion. As a result, these factors contribute to hesitancy and reluctance toward the adoption of endometrial ablation procedures, ultimately impacting the overall growth potential of the market in the healthcare landscape.

Market Trends of the Endometrial Ablation Market

The endometrial ablation market is witnessing a robust trend driven by rapid technological advancements, which are revolutionizing the landscape of minimally invasive gynecological procedures. Innovative devices boasting enhanced precision, safety, and efficacy are emerging, thus appealing to both patients seeking effective solutions for abnormal uterine bleeding and healthcare professionals desiring improved surgical outcomes. These advancements, including advanced energy-based techniques and real-time imaging, are contributing to higher patient satisfaction rates and fostering broader acceptance of these procedures within clinical settings. As a result, the market is poised for significant growth, bolstered by a heightened emphasis on women's health and patient-centered care solutions.

Introduction

Objectives of the Study
Scope of the Report
Definitions

Research Methodology

Information Procurement
Secondary & Primary Data Methods
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Global Market Outlook
Supply & Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Overview
Market Size
Market Dynamics
- Drivers & Opportunities
- Restraints & Challenges
Porters Analysis
- Competitive rivalry
- Threat of substitute
- Bargaining power of buyers
- Threat of new entrants
- Bargaining power of suppliers

Key Market Insights

Key Success Factors
Degree of Competition
Top Investment Pockets
Market Ecosystem
Market Attractiveness Index, 2024
PESTEL Analysis
Macro-Economic Indicators
Value Chain Analysis
Pricing Analysis
Case Studies
Regulatory Analysis

Global Endometrial Ablation Market Size by Product & CAGR (2025-2032)

Market Overview
Cryoablation
Radiofrequency Ablation
Hydrothermal Ablation
Thermal Balloon
Microwave Energy
Others

Global Endometrial Ablation Market Size by End-use & CAGR (2025-2032)

Market Overview
Hospitals
Clinics
Ambulatory Surgical Centers

Global Endometrial Ablation Market Size & CAGR (2025-2032)

North America (Product, End-use)
- US
- Canada
Europe (Product, End-use)
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
Asia Pacific (Product, End-use)
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America (Product, End-use)
- Brazil
- Rest of Latin America
Middle East & Africa (Product, End-use)
- GCC Countries
- South Africa
- Rest of Middle East & Africa

Competitive Intelligence

Top 5 Player Comparison
Market Positioning of Key Players, 2024
Strategies Adopted by Key Market Players
Recent Developments in the Market
Company Market Share Analysis, 2024
Company Profiles of All Key Players
- Company Details
- Product Portfolio Analysis
- Company's Segmental Share Analysis
- Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

Hologic, Inc. (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Boston Scientific Corporation (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Medtronic plc (Ireland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
CooperSurgical Inc. (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Olympus Corporation (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Smith & Nephew plc (United Kingdom)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Minerva Surgical, Inc. (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Ethicon, Inc. (Johnson & Johnson) (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
AngioDynamics, Inc. (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Myosure (Hologic, Inc.) (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments